Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
Abstract The use of sacubitril/valsartan significantly reduces death or hospitalization in patients with ejection fraction < 40%. There is no study evaluating this drug effects in non‐compaction cardiomyopathy (NCCM) individuals. The aim of this article is to report a case of a patient with NCCM ini...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020-06-01
|
| סדרה: | ESC Heart Failure |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/ehf2.12713 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|